Drug Therapy Research Award

The Drug Therapy Research Award recognizes outstanding original contributions to the peer-reviewed, primary, biomedical literature that address the therapeutic uses of medications. These can include studies of efficacy, effectiveness, safety, pharmacokinetics, pharmacogenomics, and other pharmacology, toxicology and pharmaceutical sciences research. This award is not intended to recognize practice-based or health services research. (See the Award for Innovation in Pharmacy Practice and the Pharmacy Practice Research Award for these types of research.) 

Award Description
The recipient of this award receives a $4,000 honorarium or a $3,000 honorarium, an up to $1,000 expense allowance to attend the ASHP Midyear Clinical Meeting for the award ceremony, and a plaque.

Nomination and Submission Process
The ASHP Foundation promotes this program and solicits nominations and self-nominations through our communication channels and specifically from ASHP component groups (e.g., sections, advisory groups), the editors of AJHP, and deans of schools/colleges of pharmacy. ASHP members and affiliated state societies may also nominate candidates for this award. Authors may also nominate themselves.

Submission for this program is initiated by either:
  1. Nomination: a recommendation from your peers submitted through an online survey or,
  2. Self-nomination through the online application system
An application must be submitted in order for the panel to consider an individual for the award, irrespective of the initial nomination.


• The author must be a pharmacist;
• The applicant must be either the first, corresponding, or senior author listed on the nominated article; and   
• The applicant must have participated in each of the following:
  1. Substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and
  2. Drafting the article or revising it critically for important intellectual content; and
  3. Final approval of the version to be published.
To be eligible for this award, all conditions must be met.

• The article submitted for the Drug Therapy Research Award must have been published in a PubMed-indexed, peer-reviewed biomedical journal in the 2018 calendar year (January 1, 2018 – December 31, 2018).
• Print or electronic articles that were published in 2018 are eligible for consideration.  
• Articles that were published electronically in 2017 and in print in 2018 are not eligible for consideration if the electronic version was submitted for consideration in the 2019 Literature Awards Program cycle.   

Selection Process
The ASHP Foundation reserves the right to change the categorization for submitted articles at the discretion of ASHP Foundation staff and external reviewers. For example, an article submitted for the Award for Innovation in Pharmacy Practice category could be re-classified to the Pharmacy Practice Research Award category.

Complete applications will be reviewed by members of a review panel appointed by the ASHP Foundation Board of Directors.
The recipient of the award will be notified after the review is completed, and a public announcement of the recipient will be made prior to the ASHP Midyear Clinical Meeting. Awards are formally presented during the Literature Awards Breakfast at the ASHP Midyear Clinical Meeting.

Award Recipients
Learn more about awardees chosen this year and from previous years.